MedPath

Telavancin

Generic Name
Telavancin
Brand Names
Vibativ
Drug Type
Small Molecule
Chemical Formula
C80H106Cl2N11O27P
CAS Number
372151-71-8
Unique Ingredient Identifier
XK134822Z0

Overview

Telavancin is a semi-synthetic derivative of vanocymycin that has bactericidal activity against Methicillin-resistant Staphylococcus aureus (MRSA) and other gram-positive bacteria. MRSA is an important pathogen capable of causing hospital-acquired pneumonia (HAP), ventilator-associated pneumonia (VAP), and skin and subcutaneous tissue infections among others.

Background

Telavancin is a semi-synthetic derivative of vanocymycin that has bactericidal activity against Methicillin-resistant Staphylococcus aureus (MRSA) and other gram-positive bacteria. MRSA is an important pathogen capable of causing hospital-acquired pneumonia (HAP), ventilator-associated pneumonia (VAP), and skin and subcutaneous tissue infections among others.

Indication

用于治疗革兰阳性菌耐甲氧西林金黄色葡萄球菌(MRSA)与甲氧西林敏感金黄色葡萄球菌引起的成人复杂性皮肤和皮肤结构感染,以及医院获得性和呼吸机相关细菌性肺炎(HABP/VABP)。

Associated Conditions

  • Bacterial Infections
  • Nosocomial Pneumonia
  • Ventilator Associated Bacterial Pneumonia (VABP)
  • Complicated Skin and subcutaneous tissue bacterial infection

FDA Approved Products

VIBATIV
Manufacturer:Cumberland Pharmaceuticals Inc.
Route:INTRAVENOUS
Strength:15 mg in 1 mL
Approved: 2023/11/10
NDC:66220-315
Vibativ
Manufacturer:Theravance, Inc.
Route:INTRAVENOUS
Strength:15 mg in 1 mL
Approved: 2014/03/28
NDC:52118-002
Vibativ
Manufacturer:Theravance, Inc.
Route:INTRAVENOUS
Strength:15 mg in 1 mL
Approved: 2014/03/28
NDC:52118-001

Singapore Approved Products

No Singapore products found for this drug

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

© Copyright 2025. All Rights Reserved by MedPath